Acute pulmonary artery dissection in an adult with chronic pulmonary hypertension secondary to congenital heart disease: a case report

被引:2
作者
Tomasino, Marco [1 ]
Soriano Colome, Toni [1 ]
Sambola Ayala, Antonia [1 ]
Gordon Ramirez, Blanca [1 ]
机构
[1] Vall dHebron Univ Hosp, Dept Cardiol, Paseo Vall dHebron 119, Barcelona 08035, Spain
关键词
Acute pulmonary artery dissection; D-Transposition of the great arteries; Congenital heart disease; Pulmonary hypertension; Case report;
D O I
10.1093/ehjcr/ytad508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background D-Transposition of the great arteries (d-TGA) is characterized by the aorta positioned above the right ventricle and the pulmonary artery above the left ventricle. Acute pulmonary artery dissection (PAD) is a rare and often lethal condition. We present a case report of acute PAD in an adult with d-TGA and pulmonary hypertension. Case summary A 49-year-old male with history of d-TGA palliated with an atrial switch (Mustard) operation, pulmonary venous baffle stenosis treated percutaneously, chronic pulmonary hypertension (mixed group 1 and 2), and severe dilatation of pulmonary arteries (pulmonary trunk of 75 mm) presented to the emergency department with chest pain and acute respiratory failure. Blood pressure was 106/78 mmHg, heart rate 93 b.p.m., and oxygen saturation 88% on room air. A computed tomography (CT) scan showed acute right PAD. He was not considered suitable for surgery nor percutaneous procedure. Epoprostenol was initiated to reduce parietal stress, but after initial stabilization, pulmonary venous stent baffle gradient increased and acute pulmonary oedema occurred. Epoprostenol was withdrawn, and furosemide was initiated, with good clinical response. A follow-up CT scan showed dissection morphological stabilization and false lumen thrombosis, and the patient was discharged. Discussion Pulmonary hypertension and previous pulmonary artery dilatation are reported as the main underlying conditions leading to PAD. No previous cases of PAD are described in patients with history of d-TGA and atrial switch procedure. Evidence regarding the best treatment of PAD is lacking, but it seems reasonable to reduce parietal stress using pulmonary vasodilators. Nevertheless, in patients with post-capillary pulmonary hypertension, pulmonary vasodilatation may cause important pulmonary congestion.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease
    Chiu, Shuenn-Nan
    Lu, Chun-Wei
    Lin, Ming-Tai
    Chen, Chun-An
    Wu, Mei-Hwan
    Wang, Jou-Kou
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (07):
  • [32] Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease
    Schuuring, Mark J.
    Bouma, Berto J.
    Cordina, Rachael
    Gatzoulis, Michael A.
    Budts, Werner
    Mullen, Mary P.
    Vis, Jeroen C.
    Celermajer, David
    Mulder, Barbara J. M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 164 (01) : 106 - 110
  • [33] Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
    Gatzoulis, M. A.
    Alonso-Gonzalez, R.
    Beghetti, M.
    EUROPEAN RESPIRATORY REVIEW, 2009, 18 (113) : 154 - 161
  • [34] Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Egito, EST
    Aiello, VD
    Bosisio, IBJ
    Lichtenfels, AJ
    Horta, ALM
    Saldiva, PHN
    Capelozzi, VL
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (08) : 521 - 532
  • [35] Pulmonary Artery Aneurysmal Dilatation in Adult Patients With Congenital Heart Disease
    Martinez-Quintana, Efren
    Rodriguez-Gonzalez, Fayna
    Nieto-Lago, Vicente
    WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY, 2011, 2 (03) : 375 - 379
  • [36] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    Smadja, David M.
    Gaussem, Pascale
    Mauge, Laetitia
    Lacroix, Romaric
    Gandrille, Sophie
    Remones, Veronique
    Peyrard, Severine
    Sabatier, Florence
    Bonnet, Damien
    Levy, Marilyne
    PEDIATRIC CARDIOLOGY, 2010, 31 (05) : 657 - 662
  • [37] Beneficial effect of an oral analog of prostacyclin on pulmonary hypertension secondary to congenital heart disease
    Ichida, F
    Uese, K
    Tsubata, S
    Hashimoto, I
    Hamamichi, Y
    Fukahara, K
    Murakami, A
    Miyawaki, T
    CARDIOLOGY IN THE YOUNG, 1998, 8 (02) : 205 - 210
  • [38] Beraprost sodium for pulmonary hypertension with congenital heart disease
    Suzuki, H
    Sato, S
    Tanabe, S
    Hayasaka, K
    PEDIATRICS INTERNATIONAL, 2002, 44 (05) : 528 - 529
  • [39] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    David M. Smadja
    Pascale Gaussem
    Laetitia Mauge
    Romaric Lacroix
    Sophie Gandrille
    Véronique Remones
    Séverine Peyrard
    Florence Sabatier
    Damien Bonnet
    Marilyne Lévy
    Pediatric Cardiology, 2010, 31 : 657 - 662
  • [40] Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism
    Duffels, M. G. J.
    van der Plas, M. N.
    Surie, S.
    Winter, M. M.
    Bouma, B. J.
    Groenink, M.
    van Dijk, A. P. J.
    Hoendermis, E. S.
    Berger, R. M. F.
    Bresser, P.
    Mulder, B. J. M.
    NETHERLANDS HEART JOURNAL, 2009, 17 (09) : 334 - +